Clinical Trial Update: Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports completion of a Phase 2/3 study evaluating adding entecavir to ongoing lamivudine therapy in patients co-infected with HIV an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis B

Drugs mentioned

• Baraclude (entecavir)
• Epivir (Lamivudine)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis B | Phase 2, Phase 3 | Status: COMPLETED